ALAINA NEVELS: Open Payments
NPI 1013460526 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 62 payments from 14 companies in 2025. Trend: 2023 $401 · 2024 $3,305 · 2025 $1,016
Food & beverage: $1,016
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $264 |
| Vanda Pharmaceuticals Inc. | 13 | $232 |
| Alkermes, Inc. | 5 | $111 |
| Axsome Therapeutics, Inc. | 4 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Almatica Pharma LLC | 2 | $53 |
| Indivior Inc. | 3 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: FANAPT, VRAYLAR, Auvelity, LYBALVI, CAPLYTA, QULIPTA, LOREEV XR, SUBLOCADE.
Industry payments across KY — which companies pay providers there.
